Erik L. Ridley and Kate Madden Yee

RSNA 2024
GE HealthCare targets precision care, workflow improvements
A new SPECT/CT system and a range of AI technologies aimed at improving operational efficiencies were among the highlights for GE HealthCare at RSNA 2024.
December 5, 2024
GE HealthCare's new Aurora dual-head SPECT/CT scanner. Image courtesy of GE HealthCare.
2022
Canon highlights U.S. subsidiary, new products at RSNA 2022
CHICAGO - Plans for a new U.S. subsidiary and a range of new product launches were among the highlights for Canon Medical Systems at RSNA 2022.
November 29, 2022
2022 11 30 22 59 1769 2022 11 30 Canon Cxdi Elite 20221130222539
Nuclear Medicine
GE leans into improving patient outcomes, healthcare efficiency
CHICAGO - At this year's RSNA meeting, GE Healthcare is focusing on two goals: improving patient outcomes and boosting the efficiency of the healthcare enterprise. Promotion of these themes comes just weeks before GE is set to spin off its healthcare division into a standalone firm to be called GE HealthCare, which it plans to do in January.
November 28, 2022
2021 11 30 16 39 4000 Ge Rsna 2021 400
Breast
Screening mammography sensitivity is improving, study shows
Breast imagers are doing a better job of detecting breast cancer, according to a study published online May 26 in Radiology that evaluated 2.5 million screening mammograms in the U.S. over a nine-year period.
May 26, 2010
Page 1 of 1
Top Stories
Congress
Nuclear Medicine
Controversy clouds nuclear medicine bill
Radiology societies and patient advocates are at odds over a bill in the U.S. Congress.
Breast Screening Van 400 (1)
Womens Imaging
ARRS: Mobile mammo boosts breast screening, but no-show rate still high
Amie Lee, MD, presented at ARRS 2025 on managing 'controversial' high-risk breast lesions diagnosed on core needle biopsy. This slide outlines how to manage pleomorphic lobular carcinoma in situ (LCIS) via surgical excision.
Womens Imaging
ARRS: How to manage 'controversial' high-risk breast lesions
Images show a palpable mass in the left breast in a 55-year-old woman. (A) Mammography shows a 26-mm ill-defined mass with fine linear calcifications in the central portion of the left breast (arrows). (B) ultrasound shows a 23-mm hypoechoic mass with calcifications in the corresponding area accompanying palpability (between the arrows). (C) An axial, fat-saturated, contrast-enhanced T1-weighted MRI scan shows an 18-mm irregular heterogeneous enhancing mass in the left breast (arrows). After breast-conserving surgery, the final pathologic report confirmed a grade II estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–positive invasive ductal carcinoma. There was no lymphovascular invasion, and the resection margins were clear. The patient declined both adjuvant chemotherapy and radiation therapy due to psychologic distress. (D) 11 months later, surveillance ultrasound helped to detect a new 25-mm irregular hypoechoic mass at the 12-o’clock position in the left breast (arrows). A subsequent ultrasound-guided biopsy confirmed it as a recurrence of grade II invasive ductal carcinoma, maintaining the same receptor statuses. Images courtesy of the RSNA.
Breast
Preop MRI fails to deliver results for breast cancer subtype
Representative images from diagnostic analysis of deep learning (DL)-based CT myocardial perfusion imaging (MPI). (A-D) Representative images in a 51-year-old woman with stable angina at presentation. (A) Curved planar reformation and (B) three-dimensional maximum intensity projection images show severe stenosis of the opening left anterior descending artery (arrow). (C) Fractional flow reserve (FFR) determined with invasive coronary angiography helps confirm that there was no hemodynamic significance of the opening left anterior descending artery lesion (arrow). (D) Dynamic CT MPI provided functional information to identify hemodynamically significant stenosis with reference to invasive FFR. Myocardial blood flow (MBF) derived from DL-based CT MPI revealed the absence of decreased myocardial perfusion of the left anterior descending artery territory (the areas outlined in black represent the myocardium subtended by the left anterior descending stenosis, and the color bar is a graphical scale that maps MBF ranges). (E-H) Representative images in a 62-year-old man with exertional chest pain at presentation. (E) Curved planar reformation and (F) three-dimensional maximum intensity projection images show moderate stenosis of the middle left anterior descending artery (arrow). (G) FFR determined at invasive coronary angiography helps confirm that the middle left anterior descending lesion was hemodynamically significant (arrow). (H) Dynamic CT MPI provided functional information to identify hemodynamically significant stenosis with reference to invasive FFR. DL-based CT MPI showed a reduction in MBF within the middle and basal anterior wall of the left anterior descending artery territory (the areas outlined in black represent the myocardium with decreased perfusion, and the color bar is a graphical scale that maps MBF ranges). MBFDL = MBF derived from the DL model.
CT
DL model can aid in diagnosing myocardial ischemia
More in Home
Controversy clouds nuclear medicine bill
By Will Morton
Radiology societies and patient advocates are at odds over a bill in the U.S. Congress.
May 1, 2025
Congress
ARRS: Mobile mammo boosts breast screening, but no-show rate still high
By Amerigo Allegretto
Free mobile screening mammography improves breast screening access for uninsured women, but doesn't lead to follow-up adherence.
April 30, 2025
Breast Screening Van 400 (1)
ARRS: How to manage 'controversial' high-risk breast lesions
By Amerigo Allegretto
Managing high-risk breast lesions with no consensus can be tricky, but breast radiologists can navigate this area.
April 30, 2025
Amie Lee, MD, presented at ARRS 2025 on managing 'controversial' high-risk breast lesions diagnosed on core needle biopsy. This slide outlines how to manage pleomorphic lobular carcinoma in situ (LCIS) via surgical excision.
Preop MRI fails to deliver results for breast cancer subtype
Preoperative MRI didn't improve outcomes in women with HER2-positive and hormone receptor-negative breast cancer in a new study.
April 29, 2025
Images show a palpable mass in the left breast in a 55-year-old woman. (A) Mammography shows a 26-mm ill-defined mass with fine linear calcifications in the central portion of the left breast (arrows). (B) ultrasound shows a 23-mm hypoechoic mass with calcifications in the corresponding area accompanying palpability (between the arrows). (C) An axial, fat-saturated, contrast-enhanced T1-weighted MRI scan shows an 18-mm irregular heterogeneous enhancing mass in the left breast (arrows). After breast-conserving surgery, the final pathologic report confirmed a grade II estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–positive invasive ductal carcinoma. There was no lymphovascular invasion, and the resection margins were clear. The patient declined both adjuvant chemotherapy and radiation therapy due to psychologic distress. (D) 11 months later, surveillance ultrasound helped to detect a new 25-mm irregular hypoechoic mass at the 12-o’clock position in the left breast (arrows). A subsequent ultrasound-guided biopsy confirmed it as a recurrence of grade II invasive ductal carcinoma, maintaining the same receptor statuses. Images courtesy of the RSNA.
DL model can aid in diagnosing myocardial ischemia
By Will Morton
A deep-learning (DL) model can automatically measure myocardial blood flow on CT scans to help diagnose myocardial ischemia.
April 29, 2025
Representative images from diagnostic analysis of deep learning (DL)-based CT myocardial perfusion imaging (MPI). (A-D) Representative images in a 51-year-old woman with stable angina at presentation. (A) Curved planar reformation and (B) three-dimensional maximum intensity projection images show severe stenosis of the opening left anterior descending artery (arrow). (C) Fractional flow reserve (FFR) determined with invasive coronary angiography helps confirm that there was no hemodynamic significance of the opening left anterior descending artery lesion (arrow). (D) Dynamic CT MPI provided functional information to identify hemodynamically significant stenosis with reference to invasive FFR. Myocardial blood flow (MBF) derived from DL-based CT MPI revealed the absence of decreased myocardial perfusion of the left anterior descending artery territory (the areas outlined in black represent the myocardium subtended by the left anterior descending stenosis, and the color bar is a graphical scale that maps MBF ranges). (E-H) Representative images in a 62-year-old man with exertional chest pain at presentation. (E) Curved planar reformation and (F) three-dimensional maximum intensity projection images show moderate stenosis of the middle left anterior descending artery (arrow). (G) FFR determined at invasive coronary angiography helps confirm that the middle left anterior descending lesion was hemodynamically significant (arrow). (H) Dynamic CT MPI provided functional information to identify hemodynamically significant stenosis with reference to invasive FFR. DL-based CT MPI showed a reduction in MBF within the middle and basal anterior wall of the left anterior descending artery territory (the areas outlined in black represent the myocardium with decreased perfusion, and the color bar is a graphical scale that maps MBF ranges). MBFDL = MBF derived from the DL model.
ARRS: Radiologists can help PCPs boost lung cancer screening rates
By Kate Madden Yee
Radiologists can help boost lung cancer screening uptake by educating and supporting their primary care provider peers (PCP).
April 29, 2025
Lung Cancer
ARRS: 'Neurotheranostics' may be new frontier for nuclear medicine
By Will Morton
Advances in brain PET imaging combined with new treatments for Alzheimer’s have given rise to a new concept of "neurotheranostics."
April 29, 2025
A conceptual framework for neurotheranostics.
ARRS: Rib uptake evaluation on F-18 DCFPyL PET/CT presents challenges
By Maryam Payne
Evaluating increased rib uptake on F-18 DCFPyL PET/CT in prostate cancer patients may lead to false positives.
April 28, 2025
Pet Ct Machine
ARRS: Most women OK with mammo data used to assess cancer risk
By Amerigo Allegretto
Most women are comfortable with having their mammogram data be used to calculate lifetime breast cancer risk
April 28, 2025
Mammogram Breast
ARRS: 'Report Cards' reduce BIRADS 3 usage
By Maryam Payne
"Report cards” were found to reduce rates of BI-RADS 3 assessment use, according to an award-winning poster presentation at ARRS 2025.
April 28, 2025
Breast Specialist Ultrasound Exam 400
ARRS: MASLD diagnosis may be subject to racial factors
By Kate Madden Yee
The diagnosis of metabolic-associated steatotic liver disease (MASLD) may be influenced by ethnic, racial, and social factors.
April 28, 2025
Liver Disease Stages
Mammo uptake among veterans on par with nonveterans
By Amerigo Allegretto
Female veterans are as likely to undergo screening mammography as nonveteran women.
April 25, 2025
Mammogram Patient
Page 1 of 133
Next Page